Authors:
UNTCH M
SEVIN BU
PERRAS JP
ANGIOLI R
UNTCH A
HIGHTOWER RD
KOECHLI O
AVERETTE HE
Citation: M. Untch et al., EVALUATION OF PACLITAXEL (TAXOL), CISPLATIN, AND THE COMBINATION PACLITAXEL-CISPLATIN IN OVARIAN-CANCER IN-VITRO WITH THE ATP CELL VIABILITY ASSAY, Gynecologic oncology, 53(1), 1994, pp. 44-49
Authors:
HIGHTOWER RD
NGUYEN HN
AVERETTE HE
HOSKINS W
HARRISON T
STEREN A
Citation: Rd. Hightower et al., NATIONAL SURVEY OF OVARIAN-CARCINOMA .4. PATTERNS OF CARE AND RELATEDSURVIVAL FOR OLDER PATIENTS, Cancer, 73(2), 1994, pp. 377-383
Authors:
HIGHTOWER RD
SEVIN BU
PERRAS J
NGUYEN H
ANGIOLI R
UNTCH M
AVERETTE H
Citation: Rd. Hightower et al., INVITRO EVALUATION OF THE NOVEL CHEMOTHERAPEUTIC-AGENTS U-73,975, U-77,779, AND U-80,244 IN GYNECOLOGIC CANCER CELL-LINES, Cancer investigation, 11(3), 1993, pp. 276-282
Authors:
ANGIOLI R
UNTCH M
SEVIN BU
STEREN A
HIGHTOWER RD
PERRAS JP
NGUYEN HN
KOECHLI OR
AVERETTE HE
Citation: R. Angioli et al., ENHANCEMENT OF PROGESTERONE-RECEPTOR LEVELS BY INTERFERONS IN AE-7 ENDOMETRIAL CANCER-CELLS, Cancer, 71(9), 1993, pp. 2776-2781